hepatoselective insulin (BTG)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namehepatoselective insulin (BTG)
Drug Alias Namehepatoselective insulin (Kings College/BTG)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBtg Limited
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A